The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Medetomidine, which is used to sedate pets and is somewhat similar to xylazine, was first detected in illegally manufactured ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Dr. Google is often on call for worried patients, but it may not give the best advice. Doctors say internet searches for ...

Harvey Weinstein ’s lawyers got their turn Thursday to question a woman who alleges the one-time Hollywood heavyweight held ...

But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...

Eli Lilly & Co.’s shares saw the biggest one-day drop since 2008 after CVS Health Corp. announced a plan to drop its ...

CVS Health's pharmacy benefits manager said weight-loss drugs from rival drugmaker Novo Nordisk will become the preferred ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

STORY: The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first time.A memo reviewed by Reuters Thursday says the UN agency’s ...

Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...